Financials
Financial year 2025
Apotheek Weert from Oud-Heverlee, company number BE0898636110, closed financial year 2025 with a result of € 86,735 after tax. For that financial year Apotheek Weert recorded a gross margin of € 180,285 and equity of € 366,301. Compared with financial year 2024, the result moved from € 85,901 to € 86,735. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
€ 366,301
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 86,735
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 258,368
▲ 45% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 40,000 paid out
46 % of the profit went to the shareholders, mostly to Prieels Pharma (100 % of the shares). That is where the money ends up.
People and assets in 2025
0.5
Average over the fiscal year, from the social balance sheet.
€ 42,362
▼ 14% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 165,784
▲ € 161,192 vs 2024
€ 9,518 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.
€ 148,752
▲ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,317
▲ 1% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 178,162 | € 154,808 | € 184,814 | € 180,285 | ▼ 2% |
| Profit after taxes | € 75,676 | € 66,469 | € 85,901 | € 86,735 | ▲ 1% |
| Equity | € 232,195 | € 298,664 | € 319,566 | € 366,301 | ▲ 15% |
| Total debts | € 298,864 | € 248,144 | € 154,080 | € 368,562 | ▲ 139% |
| Cash | € 194,140 | € 261,720 | € 178,290 | € 258,368 | ▲ 45% |
| Land & buildings | € 4,180 | € 2,258 | € 2,573 | € 141,590 | ▲ € 139,017 |
| Retained profit | € 222,195 | € 288,664 | € 299,566 | € 346,301 | ▲ 16% |
| Dividend | € 0 | € 0 | € 75,000 | € 40,000 | ▼ 47% |
| Bank debt | € 40,983 | € 22,864 | € 4,592 | € 165,784 | ▲ € 161,192 |
| Balance sheet total | € 531,060 | € 546,808 | € 473,645 | € 734,863 | ▲ 55% |
| Employees (FTE) | 0.7 | 0.5 | 0.5 | 0.5 |
Key figures of Apotheek Weert, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Weert?
What happened at Apotheek Weert in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 86,735 (▲ 1% vs 2024). Source: NBB ↗
- Prieëls Pharma BV stepped down as director. NBB
- W.D. Partners BV stepped down as director. NBB
- Prieëls Pharma BV became a director. NBB
- W.D. Partners BV became a director. NBB
- New establishment in Oud-Heverlee. KBO
- Start of the company according to the CBE. KBO
In short
From € 75,676 profit in 2022 to € 86,735 profit in 2025.
Paid € 95,966 in corporate taxes since 2022.
Best year ever: 2025, with € 86,735 profit.
Paid out € 115,000 in dividends to the owners in total.
A new publication or filing at Apotheek Weert? We notify you, reason included.
Follow Apotheek WeertDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Prieels Pharma, W.D. PARTNERS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek WeertThe shares are held by Prieels Pharma (100%) and W.D. PARTNERS (99.9%).
Directors
According to the 2025 annual accounts
Director · represented by Anne Willekens
since 2025 · until 2025
Director · represented by Gijs Prieëls
since 2025 · until 2025
Shareholders
100%
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Leuvensestraat 5
3051 Oud-Heverlee
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0898.636.110
- VAT number
- BE 0898.636.110
- Registered office
- Leuvensestraat 5, 3051 Oud-Heverlee
- Names & denominations
- Apotheek Weert
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 June 2008
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten